[HTML][HTML] Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

T Schmidt, V Klemis, D Schub, J Mihm, F Hielscher… - Nature medicine, 2021 - nature.com
Heterologous priming with the ChAdOx1 nCoV-19 vector vaccine followed by boosting with
a messenger RNA vaccine (BNT162b2 or mRNA-1273) is currently recommended in …

[HTML][HTML] Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous …

…, S Marx, A Abu-Omar, L Ziegler, F Hielscher… - Nature …, 2022 - nature.com
Comparative analyses of the immunogenicity and reactogenicity of homologous and
heterologous SARS-CoV-2 vaccine-regimens will inform optimized vaccine strategies. Here we …

NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens

F Hielscher, T Schmidt, V Klemis, A Wilhelm… - Journal of Clinical …, 2022 - Elsevier
Background The NVX-CoV2373-vaccine has recently been licensed, although knowledge on
vaccine-induced humoral and cellular immunity towards the parental strain and variants of …

Immunogenicity and reactogenicity of a heterologous COVID-19 prime-boost vaccination compared with homologous vaccine regimens

T Schmidt, V Klemis, D Schub, J Mihm, F Hielscher… - MedRxiv, 2021 - medrxiv.org
Heterologous priming with the ChAdOx1-nCoV-19 vector-vaccine followed by boosting with
an mRNA-vaccine is currently recommended in Germany, although data on immunogenicity …

[HTML][HTML] SARS-CoV-2-specific cellular and humoral immunity after bivalent BA. 4/5 COVID-19-vaccination in previously infected and non-infected individuals

…, S Bronder, V Klemis, S Marx, F Hielscher… - Nature …, 2024 - nature.com
Abstract Knowledge is limited as to how prior SARS-CoV-2 infection influences cellular and
humoral immunity after booster-vaccination with bivalent BA.4/5-adapted mRNA-vaccines, …

[HTML][HTML] Potent induction of humoral and cellular immunity after bivalent BA. 4/5 mRNA vaccination in dialysis patients

…, V Klemis, T Schmidt, S Marx, A Abu-Omar, F Hielscher… - npj Vaccines, 2024 - nature.com
Abstract Knowledge on immunogenicity of the bivalent Omicron BA.4/5 vaccine in dialysis
patients and the effect of a previous infection is limited. Therefore, vaccine-induced humoral …

Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) is involved in offspring bone development

…, A Raza, M Winter, F Hielscher… - Journal of Bone and …, 2019 - academic.oup.com
Embryonic growth and bone development depend on placental Ca 2+ transport across the
feto‐maternal barrier to supply minerals to the fetus. The individual factors and cellular …

Cellular and humoral immunity towards parental SARS-CoV-2 and variants of concern after two doses of the NVX-CoV2373-vaccine in comparison to homologous …

F Hielscher, T Schmidt, V Klemis, A Wilhelm, S Marx… - medRxiv, 2022 - medrxiv.org
The NVX-CoV2373-vaccine has recently been licensed, although data on vaccine-induced
humoral and cellular immunity towards the parental strain and variants of concern (VOCs) in …

[HTML][HTML] Head-to-head analysis of immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with …

…, J Mihm, S Marx, A Abu-Omar, L Ziegler, F Hielscher… - 2021 - europepmc.org
Head-to-head analyses of immunogenicity and reactogenicity between the authorized
homologous vaccine-regimens and heterologous combinations thereof are currently limited. …

[PDF][PDF] Fakultät für Mathematik

F Nestler, R Hielscher - www-user.tu-chemnitz.de
Ein wichtiger Bestandteil der angewandten Mathematik ist die Entwicklung effizienter
Algorithmen, welche vorallem in rechentechnisch aufwändigen Simulationen in verschiedenen …